Back to Journals » Journal of Pain Research » Volume 16
Knowledge Mapping of Opioids and Immunomodulation: A Bibliometric Analysis (2000–2022)
Authors Kurexi S, Wang K , Chen T
Received 21 December 2022
Accepted for publication 24 April 2023
Published 6 May 2023 Volume 2023:16 Pages 1499—1515
DOI https://doi.org/10.2147/JPR.S401326
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Timothy Atkinson
Subinuer Kurexi,1 Ke Wang,2 Tongyu Chen1
1Department of Cardiothoracic Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Acupuncture Anesthesia Clinical Research Institute, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
Correspondence: Tongyu Chen, Department of Cardiothoracic Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China, Email [email protected] Ke Wang, Acupuncture Anesthesia Clinical Research Institute, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China, Email [email protected]
Background: Increasing evidence indicates that opioids markedly affect the immune system. However, there are few studies on opioids and immunomodulation using bibliometric analysis.
Purpose: We aimed to provide a comprehensive overview of the research status and trends of the influence of opioids on immunomodulation using a bibliometric approach.
Methods: Articles related to opioids and immunomodulation published from 2000 to 2022 were obtained from the Science Citation Index Expanded of the Web of Science Core Collection by searching keywords related to opioids and immunomodulation. Bibliometric analyses and visualizations were conducted using the CiteSpace and VOSviewer software programs.
Results: From 2000 to 2022, a total of 3242 research articles on opioids and immunomodulation were published in 1126 academic journals by 16,555 authors in 3368 institutions from 102 countries/regions. A majority of publications were from the US and China, and the University of Minnesota System and Chinese Academy of Sciences were the most active institutions. Tsong-long Hwang had published the most papers, while Sabita Roy had the most cocitations. The Journal of Ethnopharmacology published the most papers on opioids and immunomodulation, the Journal of Immunology was the top cocited journal, and the major area of these publications were molecular, biological, and genetic. The top three keywords were “expression”, “activation”, and “inflammation.”
Conclusion: The number of studies on opioids and immunomodulation has increased sharply all over the world in the last two decades. This is the first bibliometric study to comprehensively summarize the collaboration network in this field. It will help scholars to understand not only the basic knowledge structure but also potential collaborations, research trend topics, and hot directions.
Keywords: opioids, immunomodulation, bibliometric analysis, VOSviewer, CiteSpace
Introduction
The term “opioids” is used broadly to describe all compounds that work at the opioid receptors, which have a long history of medicinal use. Three classical opioid receptors, which are all homologous G protein–coupled receptors — known as mu (μ), delta (δ), and kappa (κ) — were renamed MOP, DOP, KOP, respectively, in 2000.1 Endogenous opioids include enkephalin (binds to DOP), dynorphin (binds to KOP), endorphin, and endomorphine (binds to MOP).2 The nociceptin peptide receptor is classified as a nonopioid branch of the opioid receptor family, which cannot be reversed by naloxone.3 Opioid receptors are widely distributed in the human body and are vitally involved in many physiological processes.4 They are most prevalent in the central and peripheral nervous system and play a major role in pain processing, human mood, reward, and well-being, but are also widely expressed in many other tissue types regulating such functions as reproduction, growth, respiration, and immunological response.5–7
Opioid receptors and their ligands produce powerful analgesia.8,9 Opioids can also manipulate the immune system, not only participating in the functioning of immune cells but also modulating innate and adaptive immunoresponses.10 In 1979, Wybran reported that opioids can affect the rosette formation of normal human T lymphocytes, thus confirming for the first time that opioids have immunomodulatory effects on T lymphocytes.11 Research had uncovered that multiple opioid receptors are distributed on various types of immune cells.12–14 Du et al15 discovered that morphine can reduce both T-lymphocyte proliferation and the content of T-cell subtypes (CD3+, CD4+, and CD8+), while β-endorphin exerts an opposite effect on those cell populations, as well as NK cells. Met-enkephalin gives rise to promoting DC maturation and can enhance their functions.16 Beilin et al demonstrated that administration of low doses of fentanyl during the perioperative period led to faster recovery of the function of NK cells. In contrast, higher doses of fentanyl showed NK-cell suppression.17
Due to their great potential, opioids and immunomodulation are the subject of an increasing number of publications. With the rapid development of opioids and immunomodulation, many reviews have summarized relevant studies from various angles;18–20 however, we need to systematically understand the development process and research trends in the field and there is a lack of bibliometric and visualization analyses. This bibliometric study focused on both immunomodulation and opioids and the direct connections between them.
Bibliometrics is a tool that can observe the status of science and technology through overall production of science literature at a specialized level and measure science by exploring research activity among countries, scientific research institutions, and individual scientists. It is based on the act of counting and statistical methods of scientific payoff in the form of articles, publications, citations, patents, and other particular indicators. By providing new information, bibliometrics can be an aid to decision-making in science and research management. Bibliometrics cannot justify a decision or replace experts, but it can be a practical tool when used in combination with other indicators. It constitutes a way to quantify and identify the status quo and trending issues in a particular area. Nowadays, it is a fact that there is a growing demand for bibliometric data from the scientific community.21–23 This bibliometric analysis used CiteSpace and VOSviewer software to visually analyze the literature on opioids and immunomodulation from 2000 to 2022, explore this area for the first time, and describe the current situation of this field to help researchers quickly grasp information on the contributions and cooperation of authors, institutions, countries, and journals, as well as evaluate the knowledge base and trending research topics at the same time.
Methods
Data Collection
The Web of Science Core Collection contains the highest number of journal articles of international social science research. Literature related to opioids and immunomodulation was searched for on June 30, 2022 using the Science Citation Index Expanded (SCI-expanded) of the Web of Science Core Collection database. The search formulae are given in Supplementary Material 1. Original articles published in English from 2000 to 2022 were retrieved. The detailed search procedure is presented in Figure 1. Search results were downloaded as “Full record and cited references” and “Plain text.”
![]() |
Figure 1 Publication-screening flowchart. |
Data Analysis
VOSviewer (version 1.6.18) is a freely available computer program for constructing and viewing bibliometric maps. It can extract key information from numerous publications, and is often used to build collaboration, cocitation, and co-occurrence networks.24 In this study, the software mainly used for country/region and institution analysis, journal and cocited journal analysis, author and cocited author analysis, and keyword co-occurrence analysis. The nodes in the figures represent different items, while the size of circles was determined by the weight of the item, reflecting productivity. Lines between items represent links. Thicker lines mean stronger links. For building a visualization network, the number of items on each research topic was limited according to their respective condition. CiteSpace software is also an important analytical and visualization tool in the field of scientometrics and was developed by Professor Chaomei Chen.25,26 In this study, CiteSpace (version 6.1. R3) was used to calculate the centralities between countries and institutions and analyze dual maps of journals, cocited references, reference bursts, reference timelines, and keyword bursts.
Results
Annual Publications
A total of 3242 articles on opioids and immunomodulation published during 2000–2022 were obtained after screening. The annual publication and cumulative publication of the literature on opioids and immunomodulation over the past 22.5 years is presented by counting the volume of literature on opioids and immunomodulation during 2000–2022 (Figure 2). It shows that both annual and cumulative trends of opioid- and immunomodulation-related literature increased year by year: 2000–2009 could be seen as the first phase, with development being relatively slow and fluctuating; 2010–2018 could be seen as the second phase and showed a steady and obvious increase; 2019–2021 could be seen as third phase, the number of publications beginning to increase significantly and reaching a peak in 2021. By fitting the data, a statistically significant relationship was observed between publication year and the number of cumulative publications (R2=0.9826).
![]() |
Figure 2 Annual and cumulative output of research on opioids and immunomodulation. |
Literature Analysis
In Table 1, we list the 10 most-cited papers. Four of them were cited more than 500 times. The top article was “Exercise and the immune system: regulation, integration, and adaptation” by Pedersen et al, published in Physiological Reviews (IF=46.5) in 2000. This paper addressed the interactions between exercise and infectious diseases as well as exercise and neoplasia within the context of both aging and nutrition, and received 1004 citations. Among the top 10 papers, the top journal-level article was “The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states” by Ali et al, published in the Journal of the American Medical Association in 2018(IF=157.33). This study examined 333 causes and 84 risk factors and demonstrated that health in the US improved from 1990 to 2016, although the drivers of mortality and morbidity had changed in some states, with specific risk factors, such as drug-use disorders, high body-mass index, and alcohol-use disorders, being associated with adverse outcomes. Of the 10 most-cited articles, six were reviews and four were articles (Table 1).
![]() |
Table 1 Ten most-cited papers |
Distribution of Countries/Regions and Institutions
The articles retrieved in this study were from 102 countries. Figure 3A shows the geographic distribution of the 30 countries with the highest number of published papers. For better visualization, Figure 3B displays a collaboration network of the top 30 countries. Notably, there was a lot of active cooperation among these countries: different colors represent different countries, and the length of each color indicates the productivity of the corresponding country. Figure 4A presents an overlay visualization of the top 30 countries. These countries were distributed in Asia, North America, and Europe (Table 2). Among these, the country with the largest number of publications was the US (n=891, 27.5%), followed by China (n=795, 24.5%), Brazil (n=203, 6.2%), and Japan (n=195, 6.0%). The combined number of publications from China and the US accounted for over half the total (52%). In CiteSpace, centrality was used to quantify the importance of a node’s position in the network. High centrality is often well recognized as a turning point or pivotal point in a field, and thus can be seen as a “bridge.”27,28 The centrality analysis showed that the US and France had the same centrality at the top (0.25), followed by Germany (0.24) and Italy (0.19) (Table 2). Figure 4B illustrates the cooperation network of institutions. We selected 112 institutions based on a minimum number of publications of 10 for visualization. The top 10 institutions were located in five countries. The three institutions that published the most relevant papers were the University of Minnesota System (n=64, 2.0%), Chinese Academy of Sciences (n=60, 1.9%), and China Medical University (n=51, 1.6%). These institutions were also the top three institutions in terms of centrality (Table 2).
![]() |
Table 2 Top 10 countries and institutions |
![]() |
Figure 3 Geographic distribution (A) and cooperation among countries/regions (B). |
![]() |
Figure 4 Network of cooperative relationships among countries/regions (A) and visualization of institutions (B). |
Journals and Cocited Journals
A total of 1126 academic journals published articles on opioids and immunomodulation research. The top 15 journals published 620 papers, accounting for 19.12% of all publications (Table 3). The Journal of Ethnopharmacology had the greatest number of publications (n=101), followed by International Immunopharmacology (n=82) and the Journal of Neuroimmunology (n=54). Among the top 15, the journal with the highest impact factor was Brain Behavior and Immunity (IF=19.22), followed by Frontiers in Immunology (IF=8.78). We selected 59 journals based on a minimum number of publications of 10 for visualization (Figure 5A). Figure 5A shows that International Immunopharmacology had the most activecitation relationships with the Journal of Ethnopharmacology, Journal of Neuroimmunology, and Brain Behavior and Immunity.
![]() |
Table 3 Top 15 journals and cocited journals |
![]() |
Figure 5 Visualization of journals (A) and cocited journals (B). |
Among 15,196 cocited journals, 45 had more than 500 citations, among which the Journal of Immunology (3657), Proceedings of the National Academy of Sciences of the United States of America (2630), and Journal of Biological Chemistry (2307) were the top three. The impact factor of Nature was the highest (IF=69.50), followed by Science (IF=63.71) (Table 3). Journals with a minimum of 200 cocitations were filtered to map the cocitation network (Figure 5B). As shown in Figure 5B, the Journal of Immunology had positive cocitation relationships with Proceedings of the National Academy of Sciences of the United States of America, Journal of Biological Chemistry, and Journal of Neuroimmunology.
A dual-map analysis was used to reveal the connections between multiple disciplines and topic distribution of academic journals (Figure 6).29 Citing journals are on the left, cited journals are on the right, and curved paths indicate citation relationships. Figure 6 shows there were three main citation paths. The one with the strongest relationship is the path from molecular/biology/immunology journals to molecular/biology/genetics journals.
![]() |
Figure 6 Dual-map overlay of journals. |
Authors and Cocited Authors
A total of 16,555 authors participated in opioid and immunomodulation research. Among the top 10, three published more than 20 papers (Table 4). We built a collaborative network of 162 authors with five or more published papers (Figure 7A). Tsong-long Hwang published the most opioid- and immunomodulation-related articles (n=23), followed by Fengping Shan (n=22) and Sabita Roy (n=21). The relationships between authors can also be observed in this map. Fengping Shan had the highest total link strength, followed by Gilles Dietrich and Tsong-long Hwang.
![]() |
Table 4 Top 10 authors and cocited authors |
![]() |
Figure 7 Visualization of authors (A) and cocited authors (B). |
Cocited authors are two or more authors who are cited by one or more papers at the same time, and these authors constitute a cocited relationship.30 Among the 86,859 cocited authors, 119 were cocited more than 50 times. The most cocited was Sabita Roy (469), followed by Paola Sacerdote (390) and George Bogdan Stefano (305). In sum, 119 authors with a minimum cocitations of 50 were filtered to map cocitation-network graphs (Figure 7B). As shown in Figure 7B, there were also active collaborations among different cocited authors. There are five colors in this map, representing five clusters among authors. Active collaborations usually exist in the same cluster, such as Sabita Roy and Paola Sacerdote. There were also collaborations among linked two nodes in different clusters, such as Sabita Roy and Phillip Peterson.
Cocited References and Reference Bursts
Table 5 shows the 10 most-cocited references. Among these, “Mccarthy L et al (2001), Drug and Alcohol Dependence” (113), “Eisenstein TK et al (1998), Journal of Immunology” (76), and “Weber RJ et al (1989), Science” (58) were the top three. These studies had impact factors of 4.85, 5.42, and 63.71, respectively. Of the 10 references, five were articles, four reviews, and one editorial material. Cocited references were analyzed by CiteSpace for visual correlation analysis, from which the visualizations, reference burst, and timeline view of cocited references were obtained. In the connection map (Figure 8), each node represents a cited paper, the size of the nodes is closely related to the frequency of citations, and the thickness of the lines between the nodes indicates the link strength. The outermost circle in purple represents the centrality of each paper, which means it is a “bridge” paper in this mapping and has an important position in the knowledge network. The timeline perspective of the clustering diagram, combined with an analysis of clustering and time, displays the distribution of topics, trends, and interrelationships of research topics over time (Figure 9). The cluster theme is located in the rightmost diagram.
![]() |
Table 5 Top 10 cocited references |
![]() |
Figure 8 Visualization of cocited references. |
![]() |
Figure 9 Timeline of cocited references. |
The cluster analysis revealed 11 clusters: µ-opioid receptor, inflammatory pain, cancer-recurrence, HIV1 Tat, Uncaria tomentosa, low-dose naltrexone, differential alteration, ẟ-opioid receptor, opioid use disorder, chronic pain, and targeting novel mechanism. The closest clusters on the timeline were inflammatory pain (1), cancer recurrence (2), low-dose naltrexone (5), opioid-use disorder (8), and chronic pain (9). References with citation bursts are those that have been cited significantly and more frequently over a period.27 A total of 253 references were detected as citation bursts, and we chose the top 20 for Figure 10. The strongest “burstness” (strength 17.34) occurred for “Opioids and the immune system-friend or foe” by Plein et al,18 published by the British Journal of Pharmacology in 2018, with citation burstness from 2019 till today. Notably, another seven references were still in burstness. Roy et al20 reviewed opioid drug abuse and modulation of immunofunction, Exadaktylos et al retrospectively reviewed whether anesthetic technique for primary breast cancer surgery affects recurrence or metastasis,31 Al-Hashimi et al reviewed opioids and immunomodulation,32 Liang et al reviewed how the opioid system modulates immunofunction,33 Ninkovic et al reviewed the role of the µ-opioid receptor in opioid modulation of immunofunction,34 Hutchinson et al reviewed how the opioid activation of TLR4 contributes to drug reinforcement,35 and Boland et al reviewed the influence of opioids on immunofunction in patients with cancer pain.36
![]() |
Figure 10 Top 20 citation bursts. |
Keyword Analysis of Trending Research Topics
A total of 14,699 keywords were obtained, among which 588 appeared at least 10 times. Table 6 shows the top 20 keywords in research on opioids and immunomodulation. Among these, “expression”, “inflammation”, and “activation” appeared more than 300 times, which represented the main research direction of opioids and immunomodulation. We filtered keywords with more than or equal to 20 occurrences and performed cluster analysis through VOSviewer (Figure 11A). The thicker the lines between the nodes, the stronger the connection between the keywords. As shown in Figure 11A, we obtained four clusters in total, representing four research directions. Figure 11B shows the high-frequency keywords as an overlay map, where the color indicates the average published year. As we can see, oxidative stress, antioxidant, regulatory T cells, angiogenesis, and recurrence were emerging fields (in yellow). VOSviewer was also used to determine the density based on the frequency of the keywords (Figure 12A). In the density visualization, regions with higher optical density suggested a research hotspot in this area. Burst keywords between 2000 and 2022 were identified by CiteSpace. In Figure 12B, the green line represents the time period from 2000 to 2022, and the interval of the burst keyword is shown by the red line. The keyword with the greatest burst strength was “beta endorphin” (16.02). Other burst keywords presented in recent years included “pathway” (2016–2022), “regulatory T cell” (2016–2022), “antioxidant” (2017–2022), “oxidative stress” (2018–2022), “prevalence” (2018–2022), and “root” (2018–2022). In this study, we tried to objectively evaluate the hotspots and frontiers of opioid and immunomodulation research through analysis of dual-map overlay of journals (Figure 6), cocited reference timeline, and burst (Figures 9 and 10) and keyword co-occurrence, overlay, and burst (Figures 11 and 12 and Table 6).
![]() |
Table 6 Top 20 keywords |
![]() |
Figure 11 Keyword-cluster analysis (A) and overlay visualization (B). |
![]() |
Figure 12 Density visualization of keywords (A) and top 20 keywords (B). |
Discussion
Studies have shown that persons with opioid-use disorders are more likely to develop infections, including HIV.37 These findings suggest that misusing opioids is harmful to immunofunction. It has been proven that opioids have broad immunomodulatory activity.38 Most opioids were previously thought to be suppressive to the immune system, but recent research suggests that opioids may exert a dual effect, closely related to source, duration, and dose.31 In vitro and in vivo experiments have shown the different mechanisms of immunomodulation by opioids. In vitro experiments have revealed that many exogenous opioids, such as morphine impair, the phagocytic and chemotactic function of neutrophils and monocytes, reduce the effector response of B and T lymphocytes, and promote lymphocyte and phagocytic cell apoptosis. In vivo studies have also shown a detouring effect of opioids, especially morphine, involving reduction of NK-cell function and lymphocyte proliferation.10 Another experiment showed that the proliferation of spleen T lymphocytes was significantly inhibited and the contents of CD3+, CD4+, and CD8+ T lymphocytes significantly lower in a rat model of bone cancer pain than the normal control group. Such exogenous opioids as morphine can only improve pain, but have no improvement on T lymphocytes. The endogenous peptide β-endorphin can promote the proliferation of T lymphocytes, although the analgesic effect is not as good as morphine. CD3+, CD4+, and CD8+ T lymphocytes indicate that β-endorphin is beneficial to immunofunction.15
General Information
Based on the data from the SCI-expanded from 2000 to 2022, a total of 3242 opioid- and immunomodulation-related articles were published in 786 academic journals by 19,687 authors in 885 institutions from 82 countries/regions. The relevant research onficially started in 1979, when Wybran et al11 discovered that opioids had effects on immunofunction. Since then, opioid- and immunomodulation-related documents have been increasing persistently. The number of published articles in 2021 was double that of 2000. Based on to the current trend, research on opioids and immunomodulation will continue to maintain overall growth in the future.
In country/region analysis, China and the US are the principal countries involved in research on opioids and immunomodulation, and the US ranks first. About 50% of the top 10 research institutions were located in China, followed by the US (n=2, 20%), with the other three in Brazil, Italy, and Poland. Interestingly, the centrality of the US and France was the highest, while China ranked fifth. This showed that the US and France had “bridge” roles in this research field. Germany and Italy also had high centrality, which means that they also played significant roles in global cooperation on opioid and immunomodulation research. The Chinese Academy of Sciences had the highest centrality and was the second–most productive institution. When it comes to the cooperative relationships between research institutions, there were close relationships among some, such as the Chinese Academy of Sciences, China Pharmaceutical University, and Fudan University, but some had little collaboration with others, especially in geographically distant institutions. This can be harmful to the long-term development of academic research. Overlay visualization of countries indicated that although some Western countries still have strong scientific research strength, the focus of research in this field has been gradually shifting to the East, especially to Asia, in recent years.
Most of the research on opioids and immunomodulation was published in the Journal of Ethnopharmacology (IF=5.19, Q2), indicating it is currently the most popular journal in this research field. More than half of the top 15 academic journals and cocited journals could be classified as immunology and pharmacology journals, although the rest were classified as comprehensive journals covering opioids and immunomodulation. This is coordinated with the dual-map analysis, which showed the main citation paths in this research area were related to molecular, biology, immunology, genetics, and medicine. These results also suggest that researchers may select interdisciplinary journals to increase the attention of other disciplines and further enhance the research breadth and depth on opioids and immunomodulation.
Among the top 10 authors and cocited authors, as a representative scholar in this field, Sabita Roy not only ranks third in the number of papers published on opioids and immunoregulation but also first among cocited authors, with 469 citations, indicating her outstanding contribution to this field of research. Sabita Roy is a scholar at the Surgery Department of the University of Miami Miller School of Medicine, focusing on opioids and immunomodulation. In 2006, her team published a review that described the effects of morphine on innate and adaptive immunity, identified the role of the µ-opioid receptor, and discussed how morphine increased the risk of opportunistic infection.39 This paper maintained a citation burst from 2007 to 2014. Another article published in the Journal of Neuroimmune Pharmacology in 2011 has also had a reference bust from 2014 till today.20
Knowledge Base and Research Hotspots
The collection of cocited references cited by the corresponding research documents could partly represent the knowledge base.29 In this bibliometric study, we selected the 10 most-cocited references to determine the research basis on opioids and immunomodulation. Four of them were reviews, and all were focused on the immunomodulating effects of opioids.19,40–42 The other half of the top 10 were articles related to opioids and the immune system.43–47 The other one was editorial material that provide ethical guidelines for investigations of experimental pain in conscious animals.48 Of the top 10 cocited references, Mccarthy et al reviewed the relationship among opioids, opioid receptors, and immunoresponse in 2001 and received the most citations.40 Eisenstein et al reviewed opioid modulation of immunoresponse and its effects on phagocyte and lymphoid cell populations in 1998, which received the second-most.19 Richard et al suggested that periaqueductal gray matter mediates opiate-induced immunosuppression in 1989 and ranked third.43
Via keyword co-occurrence, we were able to quickly identify research hotspots in an academic area. Overlay and timeline view can elucidate the evolution of hotspots, while reference clusters and bursts are important indicators of emerging trends and research frontiers.27,49,50 In this study, the three newest burst keywords with the highest strength were “pathway”, “regulatory T cell”, and “oxidative stress.” This suggests that in recent years, research hotspots in this area focused on the pathways51–53 and roles of regulatory T cells involved in the mechanism of the immunomodulating effects of opioids,54–56 and also on oxidative stress and inflammation caused by misuse of opioids.57–59
Advantages and Limitations
The present research makes some novel contributions to this field. Firstly, this is the first bibliometric study to systematically analyze opioid- and immunomodulation-related research. It can provide an oversight of the collaboration network and research trends for scholars who pay attention to this area. Secondly, we used VOSviewer and CiteSpace to provide richer results in multiple dimensions, as well as present the results more comprehensively and objectively. However, there are some limitations in our study. On one hand, the data were only from the SCI-expanded, and other databases were ignored, and on the other hand, we chose only publications in English. Those written in languages other than English, such as Chinese, were excluded, so some relevant studies may thus have been missed.
Conclusions
Opioids are one of the most powerful analgesics available to treat pain. Nevertheless, numerous studies have shown the immunomodulating effects of opioids and suggested they modulate both innate and adaptive immunoresponses. Endogenous and exogenous opioids may play diverse roles in this process, depending on source, duration, and dose. This bibliometric study elucidates the current status and global trends of research on opioids and immunomodulation. The US and China remain in the dominant position in terms of the total number of published articles. However, the connection between countries needs to be strengthened. Based on this study, there is a strong possibility that the number of papers will increase in the coming year. It can be predicted that research on pathways, regulatory T cells, and oxidative stress will be the next hot topics and will receive increased attention.
Acknowledgments
The project was supported by the National Natural Science Foundation of China (81973644, 82074163), 2019 Project of Building Evidence-Based Practice Capacity for TCM (2019XZZX-ZJ0011), and Shanghai Clinical Research Center for Acupuncture and Moxibustion (20MC1920500).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Wang S. Historical review: opiate addiction and opioid receptors. Cell Transplant. 2019;28(3):233–238. doi:10.1177/0963689718811060
2. Toubia T, Khalife T. The endogenous opioid system: role and dysfunction caused by opioid therapy. Clin Obstet Gynecol. 2019;62(1):3–10. doi:10.1097/GRF.0000000000000409
3. James A, Williams J. Basic opioid pharmacology - an update. Br J Pain. 2020;14(2):115–121. doi:10.1177/2049463720911986
4. Wittert G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun. 1996;218(3):877–881. doi:10.1006/bbrc.1996.0156
5. Sobczak M, Salaga M, Storr MA, et al. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol. 2014;49(1):24–45. doi:10.1007/s00535-013-0753-x
6. Janecka A, Fichna J, Janecki T. Opioid receptors and their ligands. Curr Top Med Chem. 2004;4(1):1–17. doi:10.2174/1568026043451618
7. Jelen LA, Stone JM, Young AH, et al. The opioid system in depression. Neurosci Biobehav Rev. 2022;140:104800. doi:10.1016/j.neubiorev.2022.104800
8. Rodrigue D, Winkelmann J, Price M, et al. opioid misuse: an organizational response while managing cancer-related pain. Clin J Oncol Nurs. 2020;24(2):170–176. doi:10.1188/20.CJON.170-176
9. Stein C. New concepts in opioid analgesia. Expert Opin Investig Drugs. 2018;27(10):765–775. doi:10.1080/13543784.2018.1516204
10. Garcia JB, Cardoso MG, Dos-Santos MC. Opioids and the immune system: clinical relevance. Rev Bras Anestesiol. 2012;62(5):709–718. doi:10.1016/S0034-7094(12)70169-1
11. Wybran J, Appelboom T, Famaey JP, et al. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol. 1979;123(3):1068–1070. doi:10.4049/jimmunol.123.3.1068
12. Borner C, Warnick B, Smida M, et al. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling. J Immunol. 2009;183(2):882–889. doi:10.4049/jimmunol.0802763
13. Saurer TB, Carrigan KA, Ijames SG, et al. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol. 2006;173(1–2):3–11. doi:10.1016/j.jneuroim.2005.11.009
14. Li ZH, Chu N, Shan LD, et al. Inducible expression of functional mu opioid receptors in murine dendritic cells. J Neuroimmune Pharmacol. 2009;4(3):359–367. doi:10.1007/s11481-009-9145-7
15. Du JY, Liang Y, Fang JF, et al. Effect of systemic injection of heterogenous and homogenous opioids on peripheral cellular immune response in rats with bone cancer pain: a comparative study. Exp Ther Med. 2016;12(4):2568–2576. doi:10.3892/etm.2016.3647
16. Liu J, Chen W, Meng J, et al. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK). Cancer Immunol Immunother. 2012;61(10):1699–1711. doi:10.1007/s00262-012-1221-9
17. Beilin B, Shavit Y, Hart J, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996;82(3):492–497. doi:10.1097/00000539-199603000-00011
18. Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi:10.1111/bph.13750
19. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol. 1998;83(1–2):36–44. doi:10.1016/s0165-5728(97)00219-1
20. Roy S, Ninkovic J, Banerjee S, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6(4):442–465. doi:10.1007/s11481-011-9292-5
21. Okubo Y. Bibliometric indicators and analysis of research systems: methods and examples. OECD Science, Technology and Industry Working Papers; 1997.
22. Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105(3):1809–1831. doi:10.1007/s11192-015-1645-z
23. Szomszor M, Adams J, Fry R, et al. Interpreting bibliometric data. Front Res Metr Anal. 2020;5:628703. doi:10.3389/frma.2020.628703
24. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/s11192-009-0146-3
25. Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci USA. 2004;101(Suppl 1):5303–5310. doi:10.1073/pnas.0307513100
26. Chen S, Han R, Liu H. A bibliometric and visualization analysis of intermittent fasting. Front Public Health. 2022;10:946795. doi:10.3389/fpubh.2022.946795
27. Zhang J, Song L, Jia J, et al. Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis. Front Immunol. 2022;13:917155. doi:10.3389/fimmu.2022.917155
28. Pan H, Xi Z, Yu X, et al. Knowledge mapping analysis of international research on acupuncture for low back pain using bibliometrics. J Pain Res. 2021;14:3733–3746. doi:10.2147/JPR.S340992
29. Xu X, Feng C. Mapping the knowledge domain of the evolution of energy theory: a bibliometric approach. Environ Sci Pollut Res Int. 2021;28(32):43114–43142. doi:10.1007/s11356-021-14959-3
30. Ma D, Yang B, Guan B, et al. A bibliometric analysis of pyroptosis from 2001 to 2021. Front Immunol. 2021;12:731933. doi:10.3389/fimmu.2021.731933
31. Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–664. doi:10.1097/00000542-200610000-00008
32. Al-Hashimi M, Scott SW, Thompson JP, et al. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111(1):80–88. doi:10.1093/bja/aet153
33. Liang X, Liu R, Chen C, et al. Opioid system modulates the immune function: a review. Transl Perioper Pain Med. 2016;1(1):5–13. doi:10.4049/jimmunol.0802763
34. Ninkovic J, Roy S. Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids. 2013;45(1):9–24. doi:10.1007/s00726-011-1163-0
35. Hutchinson MR, Northcutt AL, Hiranita T, et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci. 2012;32(33):11187–11200. doi:10.1523/JNEUROSCI.0684-12.2012
36. Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2018;175(14):2726–2736. doi:10.1111/bph.13903
37. Wang X, Zhang T, Ho WZ. Opioids and HIV/HCV infection. J Neuroimmune Pharmacol. 2011;6(4):477–489. doi:10.1007/s11481-011-9296-1
38. Patrad E, Khalighfard S, Khori V, et al. The other side of the coin: positive view on the role of opioids in cancer. Eur J Pharmacol. 2022;923:174888. doi:10.1016/j.ejphar.2022.174888
39. Roy S, Wang J, Kelschenbach J, et al. Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol. 2006;1(1):77–89. doi:10.1007/s11481-005-9009-8
40. McCarthy L, Wetzel M, Sliker JK, et al. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 2001;62(2):111–123. doi:10.1016/s0376-8716(00
41. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11(5):354–365. doi:10.1097/01.mjt.0000132250.95650.85
42. Sharp BM, Roy S, Bidlack JM. Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol. 1998;83(1–2):45–56. doi:10.1016/S0165-5728(97)00220-8
43. Weber RJ, Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 1989;245(4914):188–190. doi:10.1126/science.2749256
44. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63. doi:10.1016/0022-1759(83
45. Lysle DT, Coussons ME, Watts VJ, et al. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther. 1993;265(3):1071–1078.
46. Szabo I, Rojavin M, Bussiere JL, et al. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther. 1993;267(2):703–706.
47. Bayer BM, Daussin S, Hernandez M, et al. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology. 1990;29(4):369–374. doi:10.1016/0028-3908(90)90096-a
48. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–110. doi:10.1016/0304-3959(83)90201-4
49. Xiao F, Li C, Sun J, et al. Knowledge domain and emerging trends in organic photovoltaic technology: a scientometric review based on CiteSpace analysis. Front Chem. 2017;5:67. doi:10.3389/fchem.2017.00067
50. Wang Y, Jia Y, Li M, et al. Hotspot and frontier analysis of exercise training therapy for heart failure complicated with depression based on web of science database and big data analysis. Front Cardiovasc Med. 2021;8:665993. doi:10.3389/fcvm.2021.665993
51. Jiang Y, Li T, Qian Y, et al. Morphine in combination with ketamine improves cervical cancer pain and suppresses immune function via the JAK3/STAT5 pathway. Pain Res Manag. 2022;2022:9364365. doi:10.1155/2022/9364365
52. Topcu KSB, Korucu EN, Menevse E, et al. Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint Vista in pancreatic cancer. Invest New Drugs. 2022;40(3):519–528. doi:10.1007/s10637-021-01209-z
53. Zhang S, Yang F, Shi R, et al. Activation of kappa-opioid receptor inhibits inflammatory response induced by sodium palmitate in human umbilical vein endothelial cells. Cytokine. 2021;146:155659. doi:10.1016/j.cyto.2021.155659
54. Shao Y, Cornwell W, Xu K, et al. Chronic exposure to the combination of cigarette smoke and morphine decreases CD4(+) regulatory T cell numbers by reprogramming the treg cell transcriptome. Front Immunol. 2022;13:887681. doi:10.3389/fimmu.2022.887681
55. Prasetya RA, Metselaar-Albers M, Engels F. Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: a pharmacodynamics perspective. Eur J Pharmacol. 2021;906:174284. doi:10.1016/j.ejphar.2021.174284
56. Peng Y, Yang J, Guo D, et al. Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3(+) regulatory T (Treg) cells in rat hepatocellular carcinoma surgical model: a randomised animal study. BMC Anesthesiol. 2020;20(1):212. doi:10.1186/s12871-020-01129-0
57. Wen S, Jiang Y, Liang S, et al. Opioids regulate the immune system: focusing on macrophages and their organelles. Front Pharmacol. 2021;12:814241. doi:10.3389/fphar.2021.814241
58. Barbaro JM, Cuervo AM, Berman JW. HIV increases the inhibitory impact of morphine and antiretrovirals on autophagy in primary human macrophages: contributions to neuropathogenesis. Cells. 2021;10:9. doi:10.3390/cells10092183
59. Salarian A, Kadkhodaee M, Zahmatkesh M, et al. Opioid use disorder induces oxidative stress and inflammation: the attenuating effect of methadone maintenance treatment. Iran J Psychiatry. 2018;13(1):46–54.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Knowledge Mapping of Acupuncture for Fibromyalgia from 1990 to 2022: A Bibliometric Analysis
Li P, Zheng H, Chen Y, Liu Z, He J
Journal of Pain Research 2022, 15:2405-2426
Published Date: 18 August 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Research Hotspots and Trends on Acupuncture for Neuropathic Pain: A Bibliometric Analysis from 2002 to 2021
Liu D, Chen B, Li T, Zheng L, Li J, Du W, Wang M, Huang Y
Journal of Pain Research 2022, 15:3381-3397
Published Date: 25 October 2022
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Knowledge Mapping of International Research on Acupuncture for Chronic Pain: A Bibliometric Analysis
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/YaB_SL94Pb0/1.jpg)
Jiao H, Ding R, Jin P, Wang J, Xu J, Tian W
Journal of Pain Research 2022, 15:3711-3728
Published Date: 2 December 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Bibliometrics Analysis and Visualization of Sarcopenia Associated with Osteoporosis from 2000 to 2022
Yang J, Jiang T, Xu G, Liu W
Journal of Pain Research 2023, 16:821-837
Published Date: 13 March 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Global Trends and Performances of Acupuncture Therapy on Bell’s Palsy from 2000 to 2023: A Bibliometric Analysis
Yu G, Luo S, Zhu C, Chen L, Huang H, Nie B, Gu J, Liu J
Journal of Pain Research 2023, 16:2155-2169
Published Date: 26 June 2023